Brief: Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing To Support Lead Program, Cnty-813
08/01/2026 13:21
Jan 8 (Reuters) - Century Therapeutics Inc IPSC.O: CENTURY THERAPEUTICS SECURES OVERSUBSCRIBED $135 MILLION PRIVATE PLACEMENT FINANCING TO SUPPORT LEAD PROGRAM, CNTY-813, A POTENTIALLY CURATIVE THERAPY FOR TYPE 1 DIABETES CENTURY THERAPEUTICS INC - FINANCING LED BY TCGX WITH MULTIPLE INVESTORS PARTICIPATING Source text: ID:nGNX3b4YdB Further company coverage: IPSC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Century Therapeutics
See all newsCentury Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Century Therapeutics Q2 net loss misses estimates on lease termination loss
Brief: Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million
Century Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Century Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview